Drug profile

The FDA adverse-event record for Calcium Carbonate

17 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Calcium Carbonate. See the species affected, top reactions, and outcomes below.

17
adverse-event reports
5.9%
death-coded share
Dog
most-reported species
4
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
17
Total Reports
1
Deaths Reported
5.9%
Death Rate

Active Ingredients

Calcium Carbonate

Administration Routes

OralUnknown

Species Affected

Dog 13
Cat 3
Human 1

Most Affected Breeds

Domestic Shorthair 3
Terrier - Jack Russell 2
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 2
Beagle 1
Terrier - Scottish 1
Poodle - Toy 1
Akita 1
Spaniel - Springer (unspecified) 1
Chihuahua 1
Pug 1

Most Reported Reactions

Vomiting 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Seizure NOS 2
Elevated blood urea nitrogen (BUN) 2
Elevated creatinine 2
Pinnal haemorrhage 2
Alopecia local 2
Crust 2
Skin scab 2
Vasculitis 2
Pinnal reddening 2
Warm feeling to the touch 2

Outcome Breakdown

Recovered/Normal
8 (47.1%)
Outcome Unknown
4 (23.5%)
Ongoing
4 (23.5%)
Died
1 (5.9%)

Calcium Carbonate Adverse Event Insights

17 reports name Calcium Carbonate; 1 recorded a death outcome (5.9% of reported events, not a population-level mortality rate). Active ingredient: Calcium Carbonate. Administration routes: Oral, Unknown.

By species: Dog (13 reports), Cat (3 reports), Human (1 reports). By breed: Domestic Shorthair (3), Terrier - Jack Russell (2), Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) (2).

Leading clinical signs: Vomiting (4), Lethargy (see also Central nervous system depression in 'Neurological') (4), Seizure NOS (2), Elevated blood urea nitrogen (BUN) (2). Outcome, 17 coded reports: Recovered/Normal leads at 47.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.